Dexrazoxane Injection, Powder, Lyophilized, For Solution
Product Images NDC 72266-235

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dexrazoxane (NDC 72266-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fosun Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dexrazoxane 250mg Carton Label

Packaging label for Dexrazoxane for Injection, 250 mg per vial, lyophilized powder dosage form for intravenous use. The label states it is sterile, pyrogen-free, and a single-dose vial. Distributed by Fosun Pharma USA Inc., made in India. Instructions on reconstitution and storage at 20° to 25°C (68° to 77°F) are included along with a barcode and NDC number 72266-235-01.*

FDA Label Image

Dexrazoxane 250mg Vial Label

Label for Dexrazoxane for Injection 250 mg per vial, sterile, pyrogen-free, lyophilized powder for intravenous use. Single-dose vial labeled by Fosun Pharma USA Inc. Instructions include storage at 20° to 25°C and preparation details. NDC 72266-235-01 is displayed, along with lot and expiration fields and a barcode.*

FDA Label Image

This Is An Image Of Dexrazoxane For Injection Vial Label (Dexrazoxane Image 3)

Label for Dexrazoxane for Injection, 500 mg per vial, a sterile, pyrogen-free, lyophilized powder for intravenous use only. The single-dose vial label includes storage instructions, manufacturer Fosun Pharma USA Inc., and identification details such as NDC, lot, and expiration date fields. The label stresses to reconstitute prior to use and contains barcode information.*

FDA Label Image

This Is An Image Of Dexrazoxane For Injection 500 mg/50 mL Vial Carton (Dexrazoxane Image 4)

Dexrazoxane for Injection 500 mg/vial lyophilized powder for intravenous use, presented in a single-dose vial. The label indicates the product is sterile and pyrogen-free, supplied by Fosun Pharma USA Inc. Instructions note reconstitution with 50 mL sterile water and storage conditions between 20° to 25°C. The packaging includes barcoding and manufacturer details.*

FDA Label Image

Dexrazoxane-image1 (Dexrazoxane Image1)

Chemical structure of Dexrazoxane showing two cyclic lactam rings connected by a methylene bridge, with multiple amide groups and a methyl substitution.*

FDA Label Image

Dexrazoxane-image2 (Dexrazoxane Image2)

A bar graph comparing the number of patients by cumulative dose of Doxorubicin (mg/m²) for two treatment groups: FAC/Dexrazoxane and FAC. The horizontal axis shows cumulative dose categories ranging from 350 to 1000+ mg/m², and the vertical axis shows the number of patients. White bars represent FAC/Dexrazoxane, and black bars represent FAC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.